Production (Stage)
CARGO Therapeutics, Inc.
CRGX
$4.37
-$0.05-1.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 45.18M | 43.97M | 41.23M | 36.53M | 28.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 188.71M | 187.37M | 172.19M | 153.79M | 122.27M |
| Operating Income | -188.71M | -187.37M | -172.19M | -153.79M | -122.27M |
| Income Before Tax | -216.19M | -167.50M | -154.14M | -147.71M | -121.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -216.19 | -167.50 | -154.14 | -147.71 | -121.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -216.19M | -167.50M | -154.14M | -147.71M | -121.21M |
| EBIT | -188.71M | -187.37M | -172.19M | -153.79M | -122.27M |
| EBITDA | -185.93M | -184.71M | -169.79M | -151.63M | -120.44M |
| EPS Basic | -4.62 | -3.73 | -4.26 | -50.75 | -76.28 |
| Normalized Basic EPS | -2.28 | -2.33 | -2.66 | -31.72 | -47.68 |
| EPS Diluted | -4.62 | -3.73 | -4.26 | -50.75 | -76.28 |
| Normalized Diluted EPS | -2.28 | -2.33 | -2.66 | -31.72 | -47.68 |
| Average Basic Shares Outstanding | 186.69M | 179.84M | 153.57M | 106.65M | 63.98M |
| Average Diluted Shares Outstanding | 186.69M | 179.84M | 153.57M | 106.65M | 63.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |